b-cells

Documents about b-cells

• Granzyme B-expressing regulatory B cells share the same origin as conventional blood B cells#159338HAL (France)
• scHG: A supercell framework with high-order graph learning enables scalable multi-omics analysis#158303PLOS
• scMagnifier: Resolving fine-grained cell subtypes via GRN-informed perturbations and consensus clustering#292689PLOS
• Design and interpretation of eQTL-GWAS colocalisation studies: Lessons from a large-scale evaluation#162582PLOS
• Modeling neonatal immune response to <i>B. pertussis</i> identifies early B cell activation and differentiation#123685PLOS
• Research advances in key genes and regulatory mechanisms of posttranslational modifications in Parkinson’s disease#400162PLOS
• CD19-targeting, 3rd Generation CAR T Cells for Refractory B Cells Malignancy#140982ClinicalTrials.gov
• Maturation of HIV-1 neutralizing antibodies in a germinal center conditional expression mouse model#302055PLOS
• Accurate quantification of spliced and unspliced transcripts for single-cell RNA sequencing with tidesurf#461616PLOS
• Anti-inflammatory Cells in Peritoneal Cavity#883016ClinicalTrials.gov
• Machine learning-driven identification of virulence determinants in <i>Borrelia burgdorferi</i> associated with human dissemination#289113PLOS
• Autoreactive B Cells in Membranous Nephropathy#805888ClinicalTrials.gov
• <b>Ctip2-mediated </b><b><i>Sp6 </i></b><b>transcriptional regulation in dental </b><b>epithelium-derived cells </b>#70253J-STAGE (Japan)
• CD19-targeting CAR T Cells for B Cell Lymphoma#910737ClinicalTrials.gov
• Dual Target CAR-T Cells in B-cell Acute Lymphoblastic Leukemia#918793ClinicalTrials.gov
• RSAD2/VIPERIN and CMPK2 coordinate an immunometabolic response to Epstein-Barr Virus#425468PLOS
• Peripheral Helper T-cells in Common Variable ImmunoDeficiency#916597ClinicalTrials.gov
• Effect of the Inhibitors of the Way JAK-STAT on Regulatory B Cells#847868ClinicalTrials.gov
• The regulation of DOCK family proteins on T and B cells#936019Repositorio de Universidad Autónoma de Chile.
• Human Blood IgA + Memory B Cells Differ From IgG + B Cells by Expressing Gut‐Homing and Regulatory Markers#218060HAL (France)
• Autologous CD22 CAR T Cells in Adults w/ Recurrent or Refractory B Cell Malignancies#831781ClinicalTrials.gov
• CART-19 Cells For R/R B-ALL#201756ClinicalTrials.gov
• The Clinical Study of CD19 UCAR-T Cells in Patients With B-cell Acute Lymphoblastic Leukemia (B-ALL)#804612ClinicalTrials.gov
• Engineered hematopoietic stem cells give rise to therapeutic antibody secreting B cells#4782Europe PMC
• Dosimetry and Biodistribution of [18F]-Fludarabine in Lymphoid Malignancies#875492ClinicalTrials.gov
• Ammonia suppresses the antitumor activity of natural killer cells and T cells by decreasing mature perforin#342756RepOD Dataverse OAI Archive
• Sub Populations of Immune Cells in Influenza A and B Patients#1010617ClinicalTrials.gov
• Characterization of the Phenotypic Markers of B Cell Lymphocytes in Rheumatoid Arthritis#897953ClinicalTrials.gov
• Loss of BECN1 does not compromise autophagosome formation but alters cargoselection and HLA-restricted antigen presentation of B cells#667095ULRR
• Chimeric Autoantibody Receptor T Cells For Targeted Depletion Of Myeloperoxidase-Specific Anti-Neutrophil Cytoplasmic Antibody-Producing B Cells#929287ScholarlyCommons
• CD19 CAR T Cells in Patients With Relapsed or Refractory CD19 Positive B-cell Lymphoma#865026ClinicalTrials.gov
• CD19-CAR-T2 Cells for CD19 Positive B Cell Malignancies#846096ClinicalTrials.gov
• The Role of B Cells and B Cell Therapies in Immune-Mediated Liver Diseases#179572Ora Oxford University Research
• "Treatment of Active HBV With γδT Cells" Clinical Trial Protocol#854095ClinicalTrials.gov
• Lymphocytic B-Leukemia (B-CLL) w/Human IL-2 Gene Modified & Human CD40 Ligand-Expressing Autologous Tumor Cells#870761ClinicalTrials.gov
• CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Large B-cell Lymphoma#834525ClinicalTrials.gov
• Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of r/r B-NHL Clinical Research#855864ClinicalTrials.gov
• T Cells Expressing Fully-human Anti-CD19 and Anti-CD20 Chimeric Antigen Receptors for Treating B-cell Malignancies and Hodgkin Lymphoma#875562ClinicalTrials.gov
• CAR-T-19 Cells for Patients With CD19+ Relapse/Refractory B-ALL#886949ClinicalTrials.gov
• Anti-CD19:TCRζ Chimeric Antigen Receptor-T Cells in the Treatment for CD19+ B Cell Lymphoma#969318ClinicalTrials.gov
• Study of Feasibility and Safety of UCD19 Chimeric Antigen Receptor (CAR) T Cells in Adult Subjects With Relapsed/Refractory (R/R) B-Cell Non-Hodgkin's Lymphoma (B-NHL)#881243ClinicalTrials.gov
• Study of 19(T2)28z1xx TRAC-Chimeric Antigen Receptor (CAR) T Cells in People With B-Cell Lymphoma#857900ClinicalTrials.gov
• Polymorphism and Auto-reactive B and T Cells Subsets in Adult's Immune Thrombocytopenia (ITP)#840207ClinicalTrials.gov
• Étude translationnelle de facteurs déterminant l’efficacité des immunothérapies par CAR T cells dans les Lymphomes diffus à grandes cellules B#175655HAL (France)
• Safety of Umbilical Cord Mesenchymal Stem Cells (UC-MSC) in Patients With Decompensated Hepatitis B Cirrhosis#872582ClinicalTrials.gov
• Synthesis And Characterization Of Azo Dyes As Sensitizers For Possible Application In Dye-Sensitized Solar Cells (DSSCS)#486333University of Ghana Digital Collections (UGSpace)
• Autologous HuCART19 T Cells Manufactured Using the CliniMACS Prodigy Platform for Pediatric B-ALL (huCART19 Prodigy)#851961ClinicalTrials.gov
• The Predictability of CD19 Expression Across Primitive Cellular Fractions of Relapsed B-ALL on Outcomes of CD19-targeted CAR T-cells#158237ClinicalTrials.gov
• Genetically Modified T-cells (CMV-Specific CD19-CAR T-cells) Plus a Vaccine (CMV-MVA Triplex) for the Treatment of Intermediate or High Grade B-Cell Non-Hodgkin Lymphoma#230466ClinicalTrials.gov
• Allogeneic Second-generation CD19-CAR T Cells for Pediatric Relapsed/Refractory B-ALL#181600ClinicalTrials.gov